【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 15
1.2 List of Figures 20
2 Introduction 22
2.1 Catalyst 22
2.2 Related Reports 23
2.3 Upcoming Related Reports 23
3 Disease Overview 24
3.1 Etiology and Pathophysiology 24
3.1.1 Etiology 24
3.1.2 Pathophysiology 25
3.1.3 Prognosis and Quality of Life 27
3.2 Symptoms 29
3.2.1 Hemophilia A and B 29
3.2.2 Inhibitors 30
4 Epidemiology 31
4.1 Disease Background 31
4.2 Risk Factors and Comorbidities 32
4.2.1 Almost 50% of hemophilia patients are affected by hypertension 33
4.3 Global Trends 34
4.4 Epidemiological Forecast of Hemophilia (2012-2022) 36
4.4.1 Forecast Methodology 36
4.4.2 Sources Used 37
4.4.3 Sources Not Used 38
4.4.4 Forecast Assumptions and Methods 38
4.5 Epidemiology Forecast (2012-2022), Hemophilia A 43
4.5.1 Diagnosed Prevalent Cases of Hemophilia A 43
4.5.2 Diagnosed Prevalent Cases of Hemophilia A by Age 45
4.5.3 Diagnosed Prevalent Cases of Hemophilia A by Sex 47
4.5.4 Age-Standardized Prevalence of Diagnosed Hemophilia A 48
4.6 Epidemiology Forecast (2012-2022), Hemophilia B 50
4.6.1 Diagnosed Prevalent Cases of Hemophilia B 50
4.6.2 Diagnosed Prevalent Cases of Hemophilia B by Age 52
4.6.3 Diagnosed Prevalent Cases of Hemophilia B by Sex 54
4.6.4 Age-Standardized Prevalence of Diagnosed Hemophilia B 56
4.7 Epidemiology Forecast (2012-2022), Hemophilia A and B 57
4.7.1 Diagnosed Prevalent Cases of Hemophilia A and B 57
4.7.2 Diagnosed Prevalent Cases of Hemophilia A and B by Sex 59
4.8 Discussion 61
4.8.1 Conclusions on Epidemiological Trends 61
4.8.2 Limitations of the Analysis 62
4.8.3 Strengths of the Analysis 63
5 Disease Management 64
5.1 Treatment Overview 64
5.1.1 Hemophilia A and B Diagnosis 65
5.1.2 Hemophilia A and B Treatment 65
5.1.3 Inhibitors Diagnosis 67
5.1.4 Inhibitors Treatment 67
5.2 US 69
5.2.1 Clinical Practice 69
5.3 France 72
5.3.1 Clinical Practice 72
5.4 Germany 74
5.4.1 Clinical Practice 74
5.5 Italy 76
5.5.1 Clinical Practice 76
5.6 Spain 78
5.6.1 Clinical Practice 78
5.7 UK 80
5.7.1 Clinical Practice 80
5.8 Japan 82
5.8.1 Clinical Practice 82
5.9 Argentina 84
5.9.1 Clinical Practice 84
5.10 China 86
5.10.1 Clinical Practice 86
6 Competitive Assessment 88
6.1 Overview 88
6.2 Strategic Competitive Assessment 89
6.3 Product Profiles – Major Brands, Hemophilia A 93
6.3.1 Advate (octocog alfa; Antihemophilic Factor [Recombinant] Plasma/Albumin-Free) 93
6.3.2 Kogenate FS/Helixate FS (Antihemophilic Factor (Recombinant)) 98
6.3.3 Xyntha/ReFacto AF (moroctocog alfa; Antihemophilic Factor [Recombinant], Plasma/Albumin-Free) 103
6.3.4 Recombinate (octocog alfa; Antihemophilic Factor [Recombinant] Plasma/Albumin-Free) 107
6.4 Product Profiles – Hemophilia B 110
6.4.1 BeneFIX (nonacog alfa; coagulation factor IX [recombinant]) 110
6.4.2 Rixubis (BAX-326) 115
6.5 Product Profiles – Hemophilia A and B with Inhibitors 120
6.5.1 NovoSeven RT (coagulation factor VIIa [recombinant]) 120
7 Opportunity and Unmet Need 123
7.1 Overview 123
7.2 Opportunities Analysis 124
7.2.1 Longer-Lasting Recombinant Factors to Reduce the Frequency of Prophylactic Injections 124
7.2.2 Lower-Cost Recombinant Replacement Therapies 125
7.2.3 Lower Risk of Inhibitor Formation in Previously Untreated Patients 126
7.2.4 More Convenient Drug Administration 126
7.2.5 Oral Formulation of Recombinant Replacement Therapies 127
7.3 Unmet Needs Gap Analysis 128
7.3.1 Long-Acting FVIII Replacement Therapies 128
7.3.2 Gene Therapy Treatments for Hemophilia A and B 128
8 Pipeline Assessment 129
8.1 Overview 129
8.2 Clinical Trial Mapping 129
8.2.1 Clinical Trials by Country 129
8.3 Clinical Trials by Phase and Trial Status 130
8.4 Promising Drugs in Clinical Development – Hemophilia A 131
8.4.1 Eloctate (rFVIII-Fc) (recombinant factor VIII fusion protein) 133
8.4.2 BAY 94-9027 (octocog alfa) 140
8.4.3 BAX-855 145
8.4.4 Novoeight (turoctocog alfa; NN7008) 150
8.4.5 N8-GP (NN7088) 155
8.4.6 CSL-627 (rFVIII-SC) 160
8.4.7 Hcl-rhFVIII 165
8.5 Promising Drugs in Clinical Development – Hemophilia B 170
8.5.1 Alprolix (rFIXFc) 172
8.5.2 CSL-654 (rIX-FP) 177
8.5.3 N9-GP (NN-7999) 182
8.5.4 IB1001 (trenacog alfa) 187
8.6 Promising Drugs in Clinical Development – Hemophilia A and B Patients with Inhibitors 192
8.6.1 BAX-817 (rFVIIa BI) 192
9 Current and Future Players 197
9.1 Overview 197
9.2 Trends in Corporate Strategy 199
9.3 Company Profiles 200
9.3.1 Baxter 200
9.3.2 Biogen Idec 204
9.3.3 Novo Nordisk 206
9.3.4 CSL Behring 209
9.3.5 Bayer 210
9.3.6 Pfizer 212
10 Market Outlook 214
10.1 Global Markets 214
10.1.1 Forecast 214
10.1.2 Drivers and Barriers – Global Issues 218
10.2 US 221
10.2.1 Forecast 221
10.2.2 Key Events 225
10.2.3 Drivers and Barriers 225
10.3 France 228
10.3.1 Forecast 228
10.3.2 Key Events 231
10.3.3 Drivers and Barriers 231
10.4 Germany 233
10.4.1 Forecast 233
10.4.2 Key Events 236
10.4.3 Drivers and Barriers 236
10.5 Italy 238
10.5.1 Forecast 238
10.5.2 Key Events 241
10.5.3 Drivers and Barriers 241
10.6 Spain 243
10.6.1 Forecast 243
10.6.2 Key Events 246
10.6.3 Drivers and Barriers 246
10.7 UK 248
10.7.1 Forecast 248
10.7.2 Key Events 251
10.7.3 Drivers and Barriers 251
10.8 Japan 254
10.8.1 Forecast 254
10.8.2 Key Events 257
10.8.3 Drivers and Barriers 257
10.9 Argentina 259
10.9.1 Forecast 259
10.9.2 Key Events 263
10.9.3 Drivers and Barriers 263
10.10 China 266
10.10.1 Forecast 266
10.10.2 Key Events 269
10.10.3 Drivers and Barriers 269
11 Appendix 271
11.1 Bibliography 271
11.2 Abbreviations 287
11.3 Methodology 290
11.4 Forecasting Methodology 290
11.4.1 Diagnosed Hemophilia Patients 291
11.4.2 Percent Drug-Treated Patients 291
11.4.3 Drugs Included in Each Therapeutic Class 291
11.4.4 Launch and Patent Expiry Dates 292
11.4.5 General Pricing Assumptions 293
11.4.6 Individual Drug Assumptions 294
11.4.7 Pricing of Pipeline Agents 298
11.5 Physicians and Specialists Included in this Study 299
11.6 About the Authors 301
11.6.1 Authors 301
11.6.2 Epidemiologists 302
11.6.3 Global Head of Healthcare 303
11.7 About GlobalData 304
11.8 Disclaimer 304
【レポート販売概要】
■ タイトル：血友病A及びB：世界市場（医薬品市場予測及び分析～2022）■ 英文：PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022
■ 発行日：2013年11月30日
■ 調査会社：GlobalData
■ 商品コード：GDATA403162999
■ 調査対象地域：グローバル
- ソフトウェア定義ネットワーク（SDN）の世界市場の規模と分析：エンドユーザー別、サービス別、ソリューション別（物理ネットワークインフラストラクチャ、仮想化/制御ソフトウェア、SDNアプリケーション）、用途別、地域別、セグメント予測、2014-2024The global SDN market is estimated to reach USD 70.41 billion by 2024, according to a new report by Grand View Research, Inc. Software defined networking has witnessed a surge in its popularity in the recent years and rightly so owing to the myriad benefits it offers over the existing legacy infrastructure. The SDN solutions provide centralized control and operational capabilities, which help the …
- Pancreatic Fistula：グローバル臨床試験レビューH1, 2013Pancreatic Fistula Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Pancreatic Fistula Global Clinical Trials Review, H1, 2013" provides data on the Pancreatic Fistula clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pancreatic Fistula. It includes an overview of the trial numbers and their recruitme …
- 自動車用熱シールドの世界市場動向及び予測Automotive heat shields are used at various locations within a vehicle to protect the vehicle body and components from excessive heat generated by the engine and exhaust systems. Technological advancements have made automotive heat shields safer and more effective over the past few years. The global automotive heat shield market, by value, is projected to grow at a CAGR of 7.8 % from 2015 to 2020 …
- 移動式発電設備レンタルの世界市場：ジェネレータ、タービンGlobal Mobile Power Generation Equipment Rentals Market: About this market Mobile power generation equipment rentals eliminate the need of end-users for installing a permanent power solution. Technavio’s mobile power generation equipment rentals market analysis considers sales from the generator and turbine segments. Our analysis also considers the sales of mobile power generation equipment rental …
- モバイルロケーションコマース2012-2018（Mobile Location Commerce 2013 – 2018）Mobile commerce is expected to grow rapidly over the next five years. This growth is driven by the introduction of the tablets and the next generation smartphones. Mind Commerce predicts that the location commerce will be one of the key initiatives across the mobile/wireless value chain within the next three years. We believe that certain key areas, such as Mobile Social Commerce in the Cloud will …
- 販売実績管理（SPM）ソリューションの世界市場：インセンティブ/報酬管理、テリトリー管理、販売計画およびモニタリング、販売分析The increasing business progressions across organizations are significantly transforming the operational patterns for organizations worldwide. This has invariably led to the obligatory need to drive sales so as to derive more revenues for the company through enhanced customer engagement. With the definite realization that boosted sales force form the core valuable asset for organizations that defi …
- ウェアラブルエレクトロニクスの世界市場2019-2023About this market The development of miniaturized electronic components is one of the key factors expected to trigger the market growth in the forthcoming years. The sleek and small design and the high operational efficiency are the prominent purchasing criteria for wearable electronic devices. The development of MEMs technology has helped the vendors in the market integrate more features into a d …
- 世界の非接続式スマートカード市場動向（2014-2018）About Contactless Smart Cards Smart cards are pocket-sized cards that are generally made of plastic and embedded with integrated circuits. They are mainly used for identification, authentication, data storage, and application processing. Smart cards are mainly of two types: contact-based and contactless. Contactless cards generally use radio-frequency induction technology for data and information …
- 世界の生化学アナライザー市場動向（2012-2016）TechNavio's analysts forecast the Global Biochemistry Analyzers market to grow at a CAGR of 4.50 percent over the period 2012-2016. One of the key factors contributing to this market growth is the advancements in technology. The Global Biochemistry Analyzers market has also been witnessing the increase in technological innovations. However, the negative impact of global recession could pose a chal …
- Noble Energy, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Noble Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Noble Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- 世界のヘリコプター市場動向（2014-2018）TechNavio's analysts forecast the Global Helicopter market to grow at a CAGR of 2.60 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing demand from civil end-users. The Global Helicopter market has also been witnessing the increase in high-altitude and versatile helicopters. However, the falling global defense budgets could pose a challenge …
- 5-アミノ-2-ニトロ安息香酸の世界市場20155-Amino-2-Nitrobenzoic Acid (CAS 13280-60-9) Market Research Report 2015 aims at providing comprehensive data on 5-Amino-2-Nitrobenzoic Acid market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes 5-Amino-2-Nitrobenzoic Acid description, covers its application areas, manufacturing methods, patterns. It captures 5-Amino-2-Nitrobenzoic Acid market trends, …
- フレキソ印刷機の世界市場2019-2023About this market The growth of the packaging industry contributes to the increase in demand for flexible packaging due to the thriving consumer goods industry and technological advances. The growth of the global packaging industry has a significant impact on the development and expansion of the global flexographic printing machine market. The food and beverage industry are estimated to be the lar …
- ヒトパピローマウイルス予防ワクチン：グローバル医薬品市場予測及び分析（～2022）PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV vaccines market is now well established, yet vaccine coverage rates amongst the traditional target population of adolescent girls remain persistently low. Initia …
- 自動車雨センサーの世界市場展望2017-20276According to Stratistics MRC, the Global Automotive Rain Sensor market is accounted for $3.34 billion in 2017 and is expected to reach $6.50 billion by 2026 growing at a CAGR of 7.6%. Improvement in technological advancements, rise in production of vehicles, and increase in demand for luxury features are the factors driving the global Automotive Rain Sensor market. However, the overall cost of veh …
